Jeff Nau, PhD, president and CEO of Oyster Point Pharma shares an update on the company's Tyrvaya product.
Jeff Nau, PhD
Advertisement
Articles by Jeff Nau, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Bausch + Lomb launches preservative-free version of Blink Triple Care eye drops
2
Exercise for the prevention and mitigation of eye disease
3
Georgia university receives state funding for state's first college of optometry
4
Recent study findings may prove previous estimations of retinal cell communication, low-light vision
5